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Abstract
Background: Lupus Nephritis (LN) is still the most 
frequent complication in Systemic Lupus Erythematous 
(SLE) patients which causing the major and 
significance morbidity and mortality. Proteinuria and 
Glomerular Filtration Rate (GFR) serves as objective 
and routine examinations to assessrenal function. 
24-hour proteinuria still regarded as gold standard 
to quantify amount protein in urine. Estimated GFR 
(eGFR) is preferably used due its convenient. On the 
hand, estimated GFR (eGFR) is preferably used due its 
convenient. However, both of them should be measured 
in order to determine renal progression and prognosis.
Only few studies have been conducted to find out the 
correlation between 24-hour proteinuria and eGFR 
in lupus nephritis patients as both of them serve as 
potential marker in progression of renal involvement. This 
study addressed to find out correlation between 24-hour 
proteinuria and eGFR in lupus nephritis patients. 
Method: Analytic-correlation study with cross-sectional 
approach at Dr. Hasan Sadikin Hospital, Bandung was 
done. Secondary data was used and paralleled with 
previous study entitled “Correlation of Random Urine 
Protein Creatinine (P-C) Ratio with 24-Hour Protein Urine 
in Lupus Nephritis Patients” carried out from October to 
December 2014.Correlation coefficient was analyzed by 
Spearmans’ correlation test. 
Results: Forty five samples were obtained based on 
inclusion criteria. Spearmans’ correlation test revealed 
non significant and very weak correlation between 24-
hour proteinuria and eGFR (r=-0.095) with p>0.05. 
Conclusion: The 24-hour proteinuria and eGFR are 
weakly correlated. Despite the weak correlation, these 
examinationsshould be considered as important markers 
to monitor prognosis of renal involvement in lupus 
nephritis patients
Keywords: Estimated glomerular filtration rate (eGFR), 
Lupus Nephritis (LN), Proteinuria, Systemic Lupus 
Erythematosus (SLE).
Background
Systemic Lupus Erythematosus (SLE) is a chronic 
autoimmune disease with multisystem clinical 
manifestations and complications ranged from 
decreasing quality of life until death.(1,2)Around 60% 
of SLE patients’ will suffer of renal involvement, 
lupus nephritis (LN), which significantly increase 
their morbidity and mortality.(3,4) Mortality rate 
in SLE patient with LN is8-fold higher than SLE 
patients without renal involvement.(5)Around 17 % 
LN patients will develop chronic kidney disease 
(CKD) or terminal stage of renal failure. This 
condition caused the requirement of a lifetime 
hemodialysis or expensive renal transplantation.(6,7)
 Most of LN are clinically asymptomatic due 
to slow declining progression ofrenal function.
(8) Both of Glomerular Filtration Rate (GFR) and 
proteinuria are currently used to assess kidney 
function.(9) Estimated GFR (eGFR) is preferably 
used instead of inulin clearance due its convenient 
and strong correlation with GFR.(9,10) On the other 
hand, proteinuria is also a strong independent 
predictor of the declining GFR and serves as 
prognostic factor in chronic kidney disease.(3,11) 
The 24-hour urine collection is still regarded as 
gold standard of proteinuria measurement although 
alternative methods are already proposed.(11) 
Several studies revealed proteinuria associates with 
the fasten progression of renal function declining 
and serves as an important marker in the etiology of 
lowered eGFR.(12) In addition, patients with heavy 
proteinuria and normal eGFR have higher mortality 
rate compared to those with low or no proteinuria 
and low eGFR.(13) Hence, it is important to assess 
both proteinuria and eGFR in patients with renal 
dysfunction, especially in lupus nephritis where 
renal flare might be occured anytime.(4) Only few 
studies have already carried out to discover the 
correlation of 24-H proteinuria and eGFR in LN 
patients.(14) This study was addressed to find out the 
correlation between 24-hour proteinuria and eGFR 
in lupus nephritis patients. 
Method
We conducted an analytic-correlative study with 
cross-sectional approach at Dr. Hasan Sadikin 
Hospital, Bandung. This study used secondary 
data and paralleled with previous study entitled 
“Correlation of Random Urine Protein Creatinine 
(P-C) Ratio with 24-Hour Protein Urine in Lupus 
Nephritis Patients”(15) carried out from October to 
December 2014. This study has alreadyapproved 
by Health Research Ethics Committee in Hasan 
Sadikin General Hospital.
 The subjects of this study were patients who 
had been diagnosed as lupus nephritis based on 
American College of Rheumatology, came to 
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Rheumatology Wards in Hasan Sadikin General Hospitalon 
October to December 2014 have regular control. Minimum 
sample required in this study is 141. However, total sampling 
method used because only 45 data were available. Eligible 
sample selected based on inclusion criteria: available data of 
complete laboratory test of 24-hour proteinuria and eGFR; and 
exclusion criteria: patients who were having menstruation, and 
suffered from other glomerulopathies, urinary tract infection, 
and inadequate 24-hour urine.(15)
 Data analysis includes: sample demographic charactertics, 
such as age, gender, and duration of having SLE; proteinuria 
measured by 24-hour urine collection method; and eGFR 
calculated by Cockcroft-Gault(4). Proteinuria was classified 
based on protein urine excretion level into 3 groups (minimal, 
moderate or non nephrotic, heavy or nephrotic). eGFR was 
classified based on “CKD prognosis on Kidney Disease: 
Improving Global Outcomes (KDIGO)” into 6 groups (Grade 
1,2,3a,3b,4,5).
 Distribution of the data was analyzed by Shappiro-Wilk 
test. Furthermore, 24-hour proteinuria and eGFR analyzed by 
Spearmans correlation test and p<0.05 considered statistically 
significance.(16) Statistical analysis was performed using 
statistical analysis software.
Result
This study involved 45 persons. The subjects’ characteristics 
are presented in Table 1.
Table 1 Characteristic of the samples 
Variable Result (45 subjects)
Age (years, Mean± SD) 32,23 ± 10,95
Gender,n(%)
•	 Female 44 (97.8)
•	 Male 1   (2.2)
Duration SLE, n(%)
•	 < 1 year 10  (22.2)
•	 ≥ 1 year 35 (77.78)
  
 The 24-hour proteinuria was classified based on amount of 
protein urine excretion each into different groups as shown in 
Table 2.
Table 2 Characteristic of 24-hour Proteinuria 
Variable Median Range
24-hour proteinuria (mg/24 hours) 387,5 52,90-5800
Classification based on protein urine 
excretion 
N (%)
•	 Minimal 31 (68.9)
•	 moderate 12 (26.7)
•	 Nephrotic or heavy 2    (4.4)
Minimal= proteinuria <1000 mg/24 hours; moderate= non 
nephrotic, proteinuria 1000-3500 mg/24 hours; heavy= nephrotic, 
proteinuria >3500mg/24 hours
The eGFR was classified based on grading of CKD in KDIGO 
guideline each into different groups as shown in Table 3.
Table 3 Characteristic of Estimated Glomerular Filtration Rate 
(eGFR) 
Variable Median Range
 Estimated Glomerular Filtration Rate (ml/min) 89,360 11,66-268,68
 KDIGOs’ classification of CKD N (%)
	•	 	Grade 1 22 (48,9)
	•	 	Grade 2 16 (35,5)
	•	 	Grade 3a 2 (4,4)
	•	 	Grade 3b 4 (8,9)
	•	 	Grade 4 0 (0)
	•	 	Grade 5 1 (2,2)
Grade 1= normal/high, eGFR ≥ 90 ml/min; Grade 2= Mildly 
decreased, eGFR 60-89 ml/min; Grade 3a= Mildly to moderately 
decreased, eGFR 45-59 ml/min; Grade 3b= Moderately to 
severely decreased, eGFR 30-44 ml/min; Grade 4= Severely 
decreased, eGFR 15-29 ml/min; Grade 5= Kidney failure, eGFR 
≤15 ml/min.
The 24-hour proteinuria was classified based on protein urine 
excretion and cross tabulated with eGFR based on KDIGO 
classification were presented in Table 4:
Table 4 Cross tabulation frequency of 24-hour proteinuria and 
eGFR
24-hour 
Proteinuria 
(mg/24 hours)
eGFR ml/min [n(%)]
KDIGO
G1 G2 G3a G3b G4 G5
Mild 16 (35.8)  12 (26.8) 1 (2.2) 2 (4.4) 0 (0.0) 0  (0.0)
Moderate   4   (8.8)   4   (8.8) 1 (2.2) 2 (4.4) 0 (0.0) 1  (2.2)
Heavy   2   (4.4)   0   (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0  (0.0)
Total 22 (49.0) 16 (35.6) 2 (4.4) 4 (8.8) 0 (0.0) 1  (2.2)
24H-Proteinuria: Minimal= proteinuria <1000 mg/24 hours; 
moderate= non nephrotic, proteinuria 1000-3500 mg/24 hours; 
heavy= nephrotic, proteinuria >3500mg/24 hours;
eGFR: Grade 1= normal/high, eGFR ≥ 90 ml/min; Grade 2= Mildly 
decreased, eGFR 60-89 ml/min; Grade 3a= Mildly to moderately 
decreased, eGFR 45-59 ml/min; Grade 3b= Moderately to 
severely decreased, eGFR 30-44 ml/min; Grade 4= Severely 
decreased, eGFR 15-29 ml/min; Grade 5= Kidney failure, eGFR 
≤15 ml/min.
Graph of analytical correlation test between 24-hour 
proteinuria and GFR used Spearmans’ correlation test was 
shown in Figure 1.
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Figure 1 Correlation between 24-hour Proteinuria and eGFR
Discussion
Our study reveals female has higher prevalence (97.8% of 
patients) than the male. Most of subjects (77.78%) have been 
diagnosed as SLE for more than 1 year. Most of subjects have 
mild proteinuria following by higher eGFR. We found a very 
weak correlation between 24-hour proteinuria and eGFR. 
 Proteinuria serves as an important marker in diagnosing 
lupus nephritis, when renal biopsy can not be performed.
(7,9) Most of the proteinuria was found with the range from 
moderate to heavy nephrotic level.(9,17) So did in our study, 
which reveals 31.1% patients who had moderate to heavy 
proteinuria. This result was also in line with the previous study 
conducted by Sircar, et al., in which revealed 42% patients 
with nephrotic proteinuria.(14)
 Glomerular Filtration Rate is a gold standard measurement 
of renal function, particularly to determine CKD grade and 
prognosis.(18,19)However, our study used eGFR as an alternative 
method of GFR measurement, since it is more convinient 
and most data had not provided the GFR measurement.(10) 
Our study revealed 84.4% of patients have low risk on CKD 
based on KDIGO classification G1 and G2. It reflected that 
most patients are well treated that resulted a significant renal 
improvement. Chronic kidney disease could not be diagnosed 
in this study, since the measurement of GFR was only 
taken once, whereas it requires, at least, 3 month to monitor 
eGFR progression to be termed as chronic kidney disease. 
Unfortunately, some of our subjects were also encountered 
declining of renal function even though receiving adequate 
therapy. It requires further analysis to determine any factors 
that affected to this result. 
 Both of proteinuria and eGFR are routinely measured 
to monitor renal function, specifically in patients with high 
proteinuria and low eGFR level.(13) This study reveals that 
most of patients who has mild proteinuria level exhibited 
normal or higher eGFR, as previously mentioned. However, 
there were 4.4% of patients had heavy proteinuria encountered 
with normal or higher eGFR based on KDIGO. This condition 
is diagnosed as membranous lupus nephritis, by considering 
the proteinuria level rather than GFR.(9) Study conducted 
in Eastern India revealed a significant and negative weak 
correlation between proteinuria and GFR.(14) The negative 
correlation result between the variables reflected higher level 
of proteinuria may lowered eGFR, hence proteinuria becomes a 
potential marker to determine renal dysfunction.(3,13)However, 
our study revealed no-significant and very weak correlation 
between 24-hour proteinuria and eGFR. We suggested that the 
no-significant and weak correlation results were impacted by 
the treatment gotten by each patients thus most of patients had 
already shown renal improvement. Furthermore, this result 
also implicated correlation between 24-hour proteinuria and 
eGFR is promising markers in order to assess kidney function 
as both of them serve as routine and objective examination in 
lupus nephritis patients.(3,9,11)
 Several studies have already conducted to discover the 
correlation between proteinuria and GFR shown various 
result.(18-21) They reported proteinuria plays a significant role 
in declining GFR, and both of them should be measured to 
assess renal function.(12,13,20) Proteinuria can be markers for 
both glomerular dysfunction and renal disease progression.(21)
However, this study reveals very weak correlation between 
24-hour proteinuria and eGFR in lupus nephritis. Most of 
patients have normal or higher eGFR and mild proteinuria 
even though diagnosed as lupus nephritis. This result most 
likely confounded by treatment undergone by the subjects, 
hence most of them show renal improvement based on 
proteinuria and eGFR level.
 Limitations of this study are samples only taken in once and 
minimum samples are not fulfilled. Every patients involved in 
this study had already received therapy that becomes potential 
confounding in this study. So, we cannot provide baseline data 
of patients before undergoing therapy. 
Conclusion
Based on this study, it is concluded there is a very weak 
correlation between 24-hour proteinuria and eGFR in 
lupus nephritis patients.Despite the weak correlation, these 
examinationsshould be considered as important markers to 
monitor prognosis of renal involvement in lupus nephritis 
patients. Further studies should be reattempted to evaluate 
these results by taking the sample periodically in order to 
monitor eGFR, considering its convenient and cost-effective 
method.
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